View ValuationUmicore 将来の成長Future 基準チェック /16Umicoreの収益は年間41.3%で減少すると予測されていますが、年間利益は年間5.9%で増加すると予測されています。EPS は年間 増加すると予測されています。自己資本利益率は 3 年後に14.8% 4.5%なると予測されています。主要情報5.9%収益成長率4.51%EPS成長率Chemicals 収益成長43.5%収益成長率-41.3%将来の株主資本利益率14.84%アナリストカバレッジGood最終更新日21 May 2026今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • May 06Umicore Announces Supervisory Board AppointmentsUmicore at its ordinary and extraordinary shareholders’ meeting held on April 30th 2026 approved the appointment of Anna Bertona and Benjamin Loh as new Supervisory Board members for a term of 3 years.お知らせ • May 03Umicore Sa Announces Chief Financial Officer Changes, Effective August 1, 2026Umicore SA announced the appointment of Lily Liu as Chief Financial Officer effective August 1, 2026. Mrs. Liu succeeds current CFO Wannes Peferoen who will leave the Company after twenty years of dedicated service. Post handover on August 1st, Mr. Peferoen will serve in a special advisory capacity until February 28, 2027 to ensure a seamless transition. Mrs. Liu joins Umicore from Synthomer, a specialty chemicals company listed on the London Stock Exchange, where she serves as CFO since July 2022. Holding both British and Australian citizenship, she brings more than twenty years of financial leadership experience across the chemicals, manufacturing, and engineering industries. Before her time at Synthomer, Mrs. Liu was CFO at Essentra plc, and previously held CFO positions with Xaar plc and Smiths Detection. She is also a non-executive director and audit committee member at DCC plc.お知らせ • Mar 30Umicore SA, Annual General Meeting, Apr 30, 2026Umicore SA, Annual General Meeting, Apr 30, 2026, at 17:00 Romance Standard Time.お知らせ • Oct 17+ 1 more updateUmicore SA to Report Fiscal Year 2025 Final Results on Mar 27, 2026Umicore SA announced that they will report fiscal year 2025 final results on Mar 27, 2026お知らせ • Aug 22Umicore SA to Report Fiscal Year 2025 Results on Feb 20, 2026Umicore SA announced that they will report fiscal year 2025 results on Feb 20, 2026お知らせ • Mar 21Umicore Announces Supervisory Board ChangesUmicore at its ordinary and special shareholders’ meetings to be held on April 24, 2025 announced after serving 10 years on Umicore’s Supervisory Board, Mr. Mark Garrett announced that he will not seek to renew his mandate at the upcoming 2025 ordinary shareholders’ meeting. Mr. Laurent Raets, Groupe Bruxelles Lambert (GBL), also announced his intention to step down from the Supervisory Board, after having served 6 years on the Board.お知らせ • Feb 17Umicore SA, Annual General Meeting, Apr 30, 2025Umicore SA, Annual General Meeting, Apr 30, 2025.お知らせ • Feb 15Umicore Sa Proposes Annual Dividend, Payable on April 30, 2025Umicore SA's Supervisory Board will propose a gross annual dividend of €0.50 per share for 2024 at the Annual General Meeting on 24 April 2025. This is a reduction from the €0.80 per share paid for 2023. Considering the interim dividend of €0.25 per share paid in August 2024, a gross amount of €0.25 per share will be paid on 30 April 2025, subject to shareholder approval. Based on the closing share price on 31 December 2024 of €9.96, the dividend yield amounts to approximately 5%.お知らせ • Feb 14Umicore SA to Report Fiscal Year 2024 Final Results on Mar 21, 2025Umicore SA announced that they will report fiscal year 2024 final results on Mar 21, 2025お知らせ • Feb 01Umicore SA to Report First Half, 2025 Results on Aug 01, 2025Umicore SA announced that they will report first half, 2025 results on Aug 01, 2025お知らせ • Dec 23+ 2 more updatesUmicore SA(ENXTBR:UMI) dropped from S&P EUROPE 350Umicore SA(ENXTBR:UMI) dropped from S&P EUROPE 350お知らせ • Sep 23Umicore SA(ENXTBR:UMI) dropped from FTSE All-World Index (USD)Umicore SA(ENXTBR:UMI) dropped from FTSE All-World Index (USD)Upcoming Dividend • Aug 14Upcoming dividend of €0.17 per shareEligible shareholders must have bought the stock before 19 August 2024. Payment date: 21 August 2024. The company is not currently making a profit but it is cash flow positive. Trailing yield: 7.0%. Within top quartile of German dividend payers (4.9%). Higher than average of industry peers (5.6%).Declared Dividend • Jul 31First half dividend of €0.17 announcedShareholders will receive a dividend of €0.17. Ex-date: 19th August 2024 Payment date: 21st August 2024 Dividend yield will be 4.4%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months. However, the dividend is covered by cash flows (57% cash payout ratio). The dividend has increased by an average of 4.8% per year over the past 10 years. However, payments have been volatile during that time.New Risk • Jul 28New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 70% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (70% net debt to equity). Paying a dividend despite being loss-making.Buy Or Sell Opportunity • Jul 28Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 36% to €13.29. The fair value is estimated to be €16.77, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 12% over the last 3 years. Meanwhile, the company became loss making.お知らせ • Jul 26Umicore SA to Report Fiscal Year 2024 Results on Feb 14, 2025Umicore SA announced that they will report fiscal year 2024 results on Feb 14, 2025Valuation Update With 7 Day Price Move • Jun 13Investor sentiment deteriorates as stock falls 10%After last week's 10% share price decline to €15.20, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 14x in the Chemicals industry in Germany. Total loss to shareholders of 68% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €13.91 per share.New Risk • Jun 13New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 4.6% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 4.6% per year for the foreseeable future. Minor Risk Dividend is not well covered by cash flows (122% cash payout ratio).Buy Or Sell Opportunity • Jun 10Now 21% overvaluedOver the last 90 days, the stock has fallen 21% to €16.62. The fair value is estimated to be €13.76, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 11%. For the next 3 years, revenue is forecast to decline by 40% per annum. Earnings are forecast to grow by 0.6% per annum over the same time period.お知らせ • May 16Umicore Announces Chief Executive Officer ChangesUmicore announced the appointment of Bart Sap as Chief Executive Officer, effective May 16th. He will succeed Mathias Miedreich who has decided to step down, in mutual agreement with the Supervisory Board. Bart Sap joined Umicore in 2004 and has been the Executive Vice President Catalysis since March 2021. His nomination is in line with the company's established succession plan. Mathias Miedreich will remain available for advice to Umicore during the next several months. Bart Sap was appointed Executive Vice-President Catalysis on March 1st, 2021. He joined Umicore in 2004 as controller for Cobalt & Specialty Materials and, after successive assignments in Korea and Belgium covering finance, supply and refining of battery raw materials, business development and operations, he became Senior Vice-President for Cobalt & Specialty Materials and Supply at the beginning of 2020. Bart holds a Master’s Degree in Commercial Science from Vlekho in Brussels, Belgium, with majors in Accountancy and Taxation.お知らせ • Apr 27+ 1 more updateUmicore Announces Supervisory Board Appointments, Effective 1 November 2024 and Appoints Frédéric Oudéa as Member of Nomination, Remuneration and Sustainability CommitteeUmicore at its ordinary and special shareholders’ meetings held on April 25, 2024, appointed Frédéric Oudéa and Philip Eykerman as new Supervisory Board members for a term of 3 years, with effect from 1 November 2024. Mr. Oudéa also joins the company’s Nomination & Remuneration Committee and its Sustainability Committee.Upcoming Dividend • Apr 22Upcoming dividend of €0.39 per shareEligible shareholders must have bought the stock before 29 April 2024. Payment date: 02 May 2024. Payout ratio is a comfortable 50% but the company is paying out more than the cash it is generating. Trailing yield: 3.8%. Lower than top quartile of German dividend payers (4.8%). Lower than average of industry peers (4.9%).お知らせ • Mar 26Umicore SA Announces Board ChangesMr. Mario Armero announced his intention to step down from the Supervisory Board at the end of this 2024 Annual General Meeting, after having served for a total of 4 years on the Board. The Supervisory Board proposes the appointment of Mr. Frédéric Oudéaas a new Supervisory Board member to replace Mr. Armero for a term of 3 years. Upon his appointment, Mr. Oudéa will also join Umicore's Nomination & Remuneration Committee and its Sustainability Committee. Frédéric Oudéa, a French citizen, is a graduate of the École Polytechnique and the École Nationale d'administration. He spent most of his career in the banking sector, at Société Générale, where he was appointed CEO from 2008 till 2023. He is currently chairman of Sanofi and senior independent director of Capgemini. He is also senior executive advisor to GBL Group.Declared Dividend • Feb 26Final dividend of €0.39 announcedShareholders will receive a dividend of €0.39. Ex-date: 29th April 2024 Payment date: 1st January 1970 Dividend yield will be 2.8%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is covered by earnings (50% earnings payout ratio) but not covered by cash flows (122% cash payout ratio). The dividend has increased by an average of 4.8% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 13% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Reported Earnings • Feb 18Full year 2023 earnings released: EPS: €1.60 (vs €2.37 in FY 2022)Full year 2023 results: EPS: €1.60 (down from €2.37 in FY 2022). Revenue: €18.4b (down 28% from FY 2022). Net income: €385.1m (down 32% from FY 2022). Profit margin: 2.1% (in line with FY 2022). Revenue is expected to decline by 37% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to grow by 2.7%. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has fallen by 24% per year, which means it is significantly lagging earnings.お知らせ • Feb 16+ 3 more updatesUmicore Proposes Dividend for the Year 2023, Payable on May 2024Umicore proposed gross annual dividend for 2023 of €0.80 of which €0.55 to be paid in May 2024, with an interim dividend of €0.25 already paid out in August 2023.New Risk • Jan 17New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 0.04% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 0.04% per year for the foreseeable future. Minor Risk Paying a dividend despite having no free cash flows.Upcoming Dividend • Aug 11Upcoming dividend of €0.17 per share at 3.1% yieldEligible shareholders must have bought the stock before 18 August 2023. Payment date: 22 August 2023. Payout ratio is a comfortable 40% but the company is not cash flow positive. Trailing yield: 3.1%. Lower than top quartile of German dividend payers (4.8%). Lower than average of industry peers (5.8%).New Risk • Aug 08New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 0.8% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 0.8% per year for the foreseeable future. Minor Risk Paying a dividend despite having no free cash flows.Reported Earnings • Aug 02First half 2023 earnings released: EPS: €0.93 (vs €1.29 in 1H 2022)First half 2023 results: EPS: €0.93 (down from €1.29 in 1H 2022). Revenue: €10.0b (down 22% from 1H 2022). Net income: €223.2m (down 28% from 1H 2022). Profit margin: 2.2% (down from 2.4% in 1H 2022). The decrease in margin was driven by lower revenue. Revenue is expected to decline by 52% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to grow by 1.8%. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.お知らせ • Jul 29Umicore SA Announces Interim Dividend, Payable on 22 August 2023Umicore SA announced interim dividend of €0.25 per share, payable on 22 August 2023 with Ex-interim dividend trading date of 18 August 2023 and Record date for the interim dividend of 21 August 2023.Upcoming Dividend • Apr 25Upcoming dividend of €0.39 per share at 2.7% yieldEligible shareholders must have bought the stock before 02 May 2023. Payment date: 04 May 2023. Payout ratio is a comfortable 34% but the company is paying out more than the cash it is generating. Trailing yield: 2.7%. Lower than top quartile of German dividend payers (4.6%). Lower than average of industry peers (5.4%).Reported Earnings • Mar 30Full year 2022 earnings released: EPS: €2.37 (vs €2.57 in FY 2021)Full year 2022 results: EPS: €2.37 (down from €2.57 in FY 2021). Revenue: €25.4b (up 5.7% from FY 2021). Net income: €569.9m (down 7.9% from FY 2021). Profit margin: 2.2% (down from 2.6% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is expected to decline by 45% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to grow by 1.8%. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.Reported Earnings • Feb 21Full year 2022 earnings released: EPS: €2.37 (vs €2.57 in FY 2021)Full year 2022 results: EPS: €2.37 (down from €2.57 in FY 2021). Revenue: €25.6b (up 6.5% from FY 2021). Net income: €569.9m (down 7.9% from FY 2021). Profit margin: 2.2% (down from 2.6% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is expected to decline by 54% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to grow by 1.4%. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.お知らせ • Feb 16Umicore SA Proposes Gross Annual Dividend for 2022, Payable on 4 May 2023Umicore SA proposed gross annual dividend for 2022 of €0.80 of which €0.55 to be paid in May 2023, with an interim dividend of €0.25 already paid out in August 2022. Ex-dividend trading date is 2 May 2023. Record date for the dividend is 3 May 2023 and payable date is 4 May 2023.お知らせ • Jan 26+ 1 more updateUmicore SA to Report First Half, 2023 Results on Jul 28, 2023Umicore SA announced that they will report first half, 2023 results on Jul 28, 2023Upcoming Dividend • Aug 12Upcoming dividend of €0.17 per shareEligible shareholders must have bought the stock before 19 August 2022. Payment date: 23 August 2022. Payout ratio is a comfortable 36% and this is well supported by cash flows. Trailing yield: 2.2%. Lower than top quartile of German dividend payers (4.5%). Lower than average of industry peers (5.6%).Reported Earnings • Aug 03First half 2022 earnings released: EPS: €1.29 (vs €1.66 in 1H 2021)First half 2022 results: EPS: €1.29 (down from €1.66 in 1H 2021). Revenue: €13.8b (up 9.2% from 1H 2021). Net income: €309.1m (down 23% from 1H 2021). Profit margin: 2.2% (down from 3.2% in 1H 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is expected to shrink by 22% compared to a 6.1% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.お知らせ • Jul 30Umicore SA to Report Fiscal Year 2022 Results on Feb 16, 2023Umicore SA announced that they will report fiscal year 2022 results on Feb 16, 2023Upcoming Dividend • Apr 27Upcoming dividend of €0.39 per shareEligible shareholders must have bought the stock before 02 May 2022. Payment date: 04 May 2022. Payout ratio is a comfortable 31% and this is well supported by cash flows. Trailing yield: 2.3%. Lower than top quartile of German dividend payers (4.0%). Lower than average of industry peers (5.0%).Reported Earnings • Mar 28Full year 2021 earnings released: EPS: €2.57 (vs €0.54 in FY 2020)Full year 2021 results: EPS: €2.57 (up from €0.54 in FY 2020). Revenue: €24.1b (up 16% from FY 2020). Net income: €619.0m (up 374% from FY 2020). Profit margin: 2.6% (up from 0.6% in FY 2020). The increase in margin was driven by higher revenue. Over the next year, revenue is expected to shrink by 83% compared to a 6.9% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.Reported Earnings • Feb 18Full year 2021 earnings: EPS in line with expectations, revenues disappointFull year 2021 results: EPS: €2.57 (up from €0.54 in FY 2020). Revenue: €24.2b (up 17% from FY 2020). Net income: €619.0m (up 374% from FY 2020). Profit margin: 2.6% (up from 0.6% in FY 2020). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 1.5%. Over the next year, revenue is expected to shrink by 83% compared to a 6.5% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.Valuation Update With 7 Day Price Move • Dec 14Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to €37.04, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 10x in the Chemicals industry in Germany. Total returns to shareholders of 6.3% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €39.58 per share.Executive Departure • Oct 12CEO & Member of Management Board Marc Grynberg has left the companyDuring their tenure, earnings grew by 16% annually compared to the industry average, which went down by 3.0%. On the 1st of October, Marc Grynberg was replaced as CEO by Mathias Miedreich after 12.9 years in the role. We don't have any record of a personal shareholding under Marc's name. A total of 2 executives have left over the last 12 months. The current median tenure of the management team is 1.50 years, which is considered inexperienced in the Simply Wall St Risk Model. Under Marc's leadership, the company delivered a total shareholder return of 1,017%.Upcoming Dividend • Aug 13Upcoming dividend of €0.17 per shareEligible shareholders must have bought the stock before 20 August 2021. Payment date: 24 August 2021. Trailing yield: 1.3%. Lower than top quartile of German dividend payers (3.1%). Lower than average of industry peers (3.5%).Reported Earnings • Aug 02First half 2021 earnings released: EPS €1.66 (vs €0.38 in 1H 2020)The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: €12.7b (up 27% from 1H 2020). Net income: €400.1m (up 340% from 1H 2020). Profit margin: 3.2% (up from 0.9% in 1H 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has increased by 1% per year.Upcoming Dividend • Apr 26Upcoming dividend of €0.35 per shareEligible shareholders must have bought the stock before 03 May 2021. Payment date: 05 May 2021. Trailing yield: 2.0%. Lower than top quartile of German dividend payers (3.2%). Lower than average of industry peers (3.5%).Is New 90 Day High Low • Mar 02New 90-day high: €49.17The company is up 31% from its price of €37.50 on 02 December 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €41.30 per share.Reported Earnings • Feb 13Full year 2020 earnings released: EPS €0.54 (vs €1.20 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: €20.7b (up 18% from FY 2019). Net income: €130.5m (down 55% from FY 2019). Profit margin: 0.6% (down from 1.6% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has remained flat, which means it is well ahead of earnings.Is New 90 Day High Low • Jan 21New 90-day high: €46.81The company is up 36% from its price of €34.38 on 23 October 2020. The German market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 22% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €14.88 per share.Is New 90 Day High Low • Dec 30New 90-day high: €39.29The company is up 10.0% from its price of €35.61 on 01 October 2020. The German market is up 9.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 18% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €9.26 per share.Is New 90 Day High Low • Oct 20New 90-day low: €34.74The company is down 23% from its price of €45.34 on 22 July 2020. The German market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €8.10 per share.Is New 90 Day High Low • Sep 25New 90-day low: €35.75The company is down 16% from its price of €42.32 on 26 June 2020. The German market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €8.41 per share.業績と収益の成長予測DB:NVJP - アナリストの将来予測と過去の財務データ ( )EUR Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/20283,992470313811812/31/20273,9224212407301012/31/20263,7843903526601012/31/202519,388385386711N/A9/30/202517,753257221590N/A6/30/202516,11512957470N/A3/31/202515,492-676172669N/A12/31/202414,869-1,480287869N/A9/30/202415,292-1,3953131,015N/A6/30/202415,715-1,3103401,160N/A3/31/202416,998-4632491,102N/A12/31/202318,2803851581,043N/A9/30/202320,4264352764N/A6/30/202322,571484-153486N/A3/31/202324,010527-5560N/A12/31/202225,449570143634N/A9/30/202224,863549307771N/A6/30/202224,278528470908N/A3/31/202224,1725736561,083N/A12/31/202124,0666198431,259N/A9/30/202123,7465297241,155N/A6/30/202123,4274406051,052N/A3/31/202122,072285352790N/A12/31/202020,71613199528N/A9/30/202020,29818050506N/A6/30/202019,8802301483N/A3/31/202018,687259-49481N/A12/31/201917,494288-99479N/A9/30/201916,223296N/A333N/A6/30/201914,953304N/A187N/A3/31/201914,339311N/A80N/A12/31/201813,726317N/A-27N/A9/30/201812,895291N/A53N/A6/30/201812,063265N/A133N/A3/31/201812,010240N/A143N/A12/31/201711,957215N/A153N/A9/30/201711,913204N/A211N/A6/30/201711,870194N/A268N/A3/31/201711,157187N/A326N/A12/31/201610,444181N/A385N/A9/30/20169,957175N/A384N/A6/30/20169,471168N/A382N/A3/31/20169,584161N/A324N/A12/31/20159,698153N/A265N/A9/30/20159,957175N/A263N/A6/30/20159,161170N/A253N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: NVJPの予測収益成長率 (年間5.9% ) は 貯蓄率 ( 1.9% ) を上回っています。収益対市場: NVJPの収益 ( 5.9% ) German市場 ( 17.1% ) よりも低い成長が予測されています。高成長収益: NVJPの収益は増加すると予測されていますが、大幅には増加しません。収益対市場: NVJPの収益は今後 3 年間で減少すると予想されています (年間-41.3% )。高い収益成長: NVJPの収益は今後 3 年間で減少すると予測されています (年間-41.3% )。一株当たり利益成長率予想将来の株主資本利益率将来のROE: NVJPの 自己資本利益率 は、3年後には低くなると予測されています ( 14.8 %)。成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/24 06:09終値2026/05/22 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Umicore SA 12 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。33 アナリスト機関Rupesh MadlaniBarclaysJames StewartBarclaysSebastian BrayBerenberg30 その他のアナリストを表示
お知らせ • May 06Umicore Announces Supervisory Board AppointmentsUmicore at its ordinary and extraordinary shareholders’ meeting held on April 30th 2026 approved the appointment of Anna Bertona and Benjamin Loh as new Supervisory Board members for a term of 3 years.
お知らせ • May 03Umicore Sa Announces Chief Financial Officer Changes, Effective August 1, 2026Umicore SA announced the appointment of Lily Liu as Chief Financial Officer effective August 1, 2026. Mrs. Liu succeeds current CFO Wannes Peferoen who will leave the Company after twenty years of dedicated service. Post handover on August 1st, Mr. Peferoen will serve in a special advisory capacity until February 28, 2027 to ensure a seamless transition. Mrs. Liu joins Umicore from Synthomer, a specialty chemicals company listed on the London Stock Exchange, where she serves as CFO since July 2022. Holding both British and Australian citizenship, she brings more than twenty years of financial leadership experience across the chemicals, manufacturing, and engineering industries. Before her time at Synthomer, Mrs. Liu was CFO at Essentra plc, and previously held CFO positions with Xaar plc and Smiths Detection. She is also a non-executive director and audit committee member at DCC plc.
お知らせ • Mar 30Umicore SA, Annual General Meeting, Apr 30, 2026Umicore SA, Annual General Meeting, Apr 30, 2026, at 17:00 Romance Standard Time.
お知らせ • Oct 17+ 1 more updateUmicore SA to Report Fiscal Year 2025 Final Results on Mar 27, 2026Umicore SA announced that they will report fiscal year 2025 final results on Mar 27, 2026
お知らせ • Aug 22Umicore SA to Report Fiscal Year 2025 Results on Feb 20, 2026Umicore SA announced that they will report fiscal year 2025 results on Feb 20, 2026
お知らせ • Mar 21Umicore Announces Supervisory Board ChangesUmicore at its ordinary and special shareholders’ meetings to be held on April 24, 2025 announced after serving 10 years on Umicore’s Supervisory Board, Mr. Mark Garrett announced that he will not seek to renew his mandate at the upcoming 2025 ordinary shareholders’ meeting. Mr. Laurent Raets, Groupe Bruxelles Lambert (GBL), also announced his intention to step down from the Supervisory Board, after having served 6 years on the Board.
お知らせ • Feb 17Umicore SA, Annual General Meeting, Apr 30, 2025Umicore SA, Annual General Meeting, Apr 30, 2025.
お知らせ • Feb 15Umicore Sa Proposes Annual Dividend, Payable on April 30, 2025Umicore SA's Supervisory Board will propose a gross annual dividend of €0.50 per share for 2024 at the Annual General Meeting on 24 April 2025. This is a reduction from the €0.80 per share paid for 2023. Considering the interim dividend of €0.25 per share paid in August 2024, a gross amount of €0.25 per share will be paid on 30 April 2025, subject to shareholder approval. Based on the closing share price on 31 December 2024 of €9.96, the dividend yield amounts to approximately 5%.
お知らせ • Feb 14Umicore SA to Report Fiscal Year 2024 Final Results on Mar 21, 2025Umicore SA announced that they will report fiscal year 2024 final results on Mar 21, 2025
お知らせ • Feb 01Umicore SA to Report First Half, 2025 Results on Aug 01, 2025Umicore SA announced that they will report first half, 2025 results on Aug 01, 2025
お知らせ • Dec 23+ 2 more updatesUmicore SA(ENXTBR:UMI) dropped from S&P EUROPE 350Umicore SA(ENXTBR:UMI) dropped from S&P EUROPE 350
お知らせ • Sep 23Umicore SA(ENXTBR:UMI) dropped from FTSE All-World Index (USD)Umicore SA(ENXTBR:UMI) dropped from FTSE All-World Index (USD)
Upcoming Dividend • Aug 14Upcoming dividend of €0.17 per shareEligible shareholders must have bought the stock before 19 August 2024. Payment date: 21 August 2024. The company is not currently making a profit but it is cash flow positive. Trailing yield: 7.0%. Within top quartile of German dividend payers (4.9%). Higher than average of industry peers (5.6%).
Declared Dividend • Jul 31First half dividend of €0.17 announcedShareholders will receive a dividend of €0.17. Ex-date: 19th August 2024 Payment date: 21st August 2024 Dividend yield will be 4.4%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months. However, the dividend is covered by cash flows (57% cash payout ratio). The dividend has increased by an average of 4.8% per year over the past 10 years. However, payments have been volatile during that time.
New Risk • Jul 28New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 70% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (70% net debt to equity). Paying a dividend despite being loss-making.
Buy Or Sell Opportunity • Jul 28Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 36% to €13.29. The fair value is estimated to be €16.77, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 12% over the last 3 years. Meanwhile, the company became loss making.
お知らせ • Jul 26Umicore SA to Report Fiscal Year 2024 Results on Feb 14, 2025Umicore SA announced that they will report fiscal year 2024 results on Feb 14, 2025
Valuation Update With 7 Day Price Move • Jun 13Investor sentiment deteriorates as stock falls 10%After last week's 10% share price decline to €15.20, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 14x in the Chemicals industry in Germany. Total loss to shareholders of 68% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €13.91 per share.
New Risk • Jun 13New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 4.6% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 4.6% per year for the foreseeable future. Minor Risk Dividend is not well covered by cash flows (122% cash payout ratio).
Buy Or Sell Opportunity • Jun 10Now 21% overvaluedOver the last 90 days, the stock has fallen 21% to €16.62. The fair value is estimated to be €13.76, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 11%. For the next 3 years, revenue is forecast to decline by 40% per annum. Earnings are forecast to grow by 0.6% per annum over the same time period.
お知らせ • May 16Umicore Announces Chief Executive Officer ChangesUmicore announced the appointment of Bart Sap as Chief Executive Officer, effective May 16th. He will succeed Mathias Miedreich who has decided to step down, in mutual agreement with the Supervisory Board. Bart Sap joined Umicore in 2004 and has been the Executive Vice President Catalysis since March 2021. His nomination is in line with the company's established succession plan. Mathias Miedreich will remain available for advice to Umicore during the next several months. Bart Sap was appointed Executive Vice-President Catalysis on March 1st, 2021. He joined Umicore in 2004 as controller for Cobalt & Specialty Materials and, after successive assignments in Korea and Belgium covering finance, supply and refining of battery raw materials, business development and operations, he became Senior Vice-President for Cobalt & Specialty Materials and Supply at the beginning of 2020. Bart holds a Master’s Degree in Commercial Science from Vlekho in Brussels, Belgium, with majors in Accountancy and Taxation.
お知らせ • Apr 27+ 1 more updateUmicore Announces Supervisory Board Appointments, Effective 1 November 2024 and Appoints Frédéric Oudéa as Member of Nomination, Remuneration and Sustainability CommitteeUmicore at its ordinary and special shareholders’ meetings held on April 25, 2024, appointed Frédéric Oudéa and Philip Eykerman as new Supervisory Board members for a term of 3 years, with effect from 1 November 2024. Mr. Oudéa also joins the company’s Nomination & Remuneration Committee and its Sustainability Committee.
Upcoming Dividend • Apr 22Upcoming dividend of €0.39 per shareEligible shareholders must have bought the stock before 29 April 2024. Payment date: 02 May 2024. Payout ratio is a comfortable 50% but the company is paying out more than the cash it is generating. Trailing yield: 3.8%. Lower than top quartile of German dividend payers (4.8%). Lower than average of industry peers (4.9%).
お知らせ • Mar 26Umicore SA Announces Board ChangesMr. Mario Armero announced his intention to step down from the Supervisory Board at the end of this 2024 Annual General Meeting, after having served for a total of 4 years on the Board. The Supervisory Board proposes the appointment of Mr. Frédéric Oudéaas a new Supervisory Board member to replace Mr. Armero for a term of 3 years. Upon his appointment, Mr. Oudéa will also join Umicore's Nomination & Remuneration Committee and its Sustainability Committee. Frédéric Oudéa, a French citizen, is a graduate of the École Polytechnique and the École Nationale d'administration. He spent most of his career in the banking sector, at Société Générale, where he was appointed CEO from 2008 till 2023. He is currently chairman of Sanofi and senior independent director of Capgemini. He is also senior executive advisor to GBL Group.
Declared Dividend • Feb 26Final dividend of €0.39 announcedShareholders will receive a dividend of €0.39. Ex-date: 29th April 2024 Payment date: 1st January 1970 Dividend yield will be 2.8%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is covered by earnings (50% earnings payout ratio) but not covered by cash flows (122% cash payout ratio). The dividend has increased by an average of 4.8% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 13% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Reported Earnings • Feb 18Full year 2023 earnings released: EPS: €1.60 (vs €2.37 in FY 2022)Full year 2023 results: EPS: €1.60 (down from €2.37 in FY 2022). Revenue: €18.4b (down 28% from FY 2022). Net income: €385.1m (down 32% from FY 2022). Profit margin: 2.1% (in line with FY 2022). Revenue is expected to decline by 37% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to grow by 2.7%. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has fallen by 24% per year, which means it is significantly lagging earnings.
お知らせ • Feb 16+ 3 more updatesUmicore Proposes Dividend for the Year 2023, Payable on May 2024Umicore proposed gross annual dividend for 2023 of €0.80 of which €0.55 to be paid in May 2024, with an interim dividend of €0.25 already paid out in August 2023.
New Risk • Jan 17New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 0.04% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 0.04% per year for the foreseeable future. Minor Risk Paying a dividend despite having no free cash flows.
Upcoming Dividend • Aug 11Upcoming dividend of €0.17 per share at 3.1% yieldEligible shareholders must have bought the stock before 18 August 2023. Payment date: 22 August 2023. Payout ratio is a comfortable 40% but the company is not cash flow positive. Trailing yield: 3.1%. Lower than top quartile of German dividend payers (4.8%). Lower than average of industry peers (5.8%).
New Risk • Aug 08New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 0.8% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 0.8% per year for the foreseeable future. Minor Risk Paying a dividend despite having no free cash flows.
Reported Earnings • Aug 02First half 2023 earnings released: EPS: €0.93 (vs €1.29 in 1H 2022)First half 2023 results: EPS: €0.93 (down from €1.29 in 1H 2022). Revenue: €10.0b (down 22% from 1H 2022). Net income: €223.2m (down 28% from 1H 2022). Profit margin: 2.2% (down from 2.4% in 1H 2022). The decrease in margin was driven by lower revenue. Revenue is expected to decline by 52% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to grow by 1.8%. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.
お知らせ • Jul 29Umicore SA Announces Interim Dividend, Payable on 22 August 2023Umicore SA announced interim dividend of €0.25 per share, payable on 22 August 2023 with Ex-interim dividend trading date of 18 August 2023 and Record date for the interim dividend of 21 August 2023.
Upcoming Dividend • Apr 25Upcoming dividend of €0.39 per share at 2.7% yieldEligible shareholders must have bought the stock before 02 May 2023. Payment date: 04 May 2023. Payout ratio is a comfortable 34% but the company is paying out more than the cash it is generating. Trailing yield: 2.7%. Lower than top quartile of German dividend payers (4.6%). Lower than average of industry peers (5.4%).
Reported Earnings • Mar 30Full year 2022 earnings released: EPS: €2.37 (vs €2.57 in FY 2021)Full year 2022 results: EPS: €2.37 (down from €2.57 in FY 2021). Revenue: €25.4b (up 5.7% from FY 2021). Net income: €569.9m (down 7.9% from FY 2021). Profit margin: 2.2% (down from 2.6% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is expected to decline by 45% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to grow by 1.8%. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
Reported Earnings • Feb 21Full year 2022 earnings released: EPS: €2.37 (vs €2.57 in FY 2021)Full year 2022 results: EPS: €2.37 (down from €2.57 in FY 2021). Revenue: €25.6b (up 6.5% from FY 2021). Net income: €569.9m (down 7.9% from FY 2021). Profit margin: 2.2% (down from 2.6% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is expected to decline by 54% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to grow by 1.4%. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.
お知らせ • Feb 16Umicore SA Proposes Gross Annual Dividend for 2022, Payable on 4 May 2023Umicore SA proposed gross annual dividend for 2022 of €0.80 of which €0.55 to be paid in May 2023, with an interim dividend of €0.25 already paid out in August 2022. Ex-dividend trading date is 2 May 2023. Record date for the dividend is 3 May 2023 and payable date is 4 May 2023.
お知らせ • Jan 26+ 1 more updateUmicore SA to Report First Half, 2023 Results on Jul 28, 2023Umicore SA announced that they will report first half, 2023 results on Jul 28, 2023
Upcoming Dividend • Aug 12Upcoming dividend of €0.17 per shareEligible shareholders must have bought the stock before 19 August 2022. Payment date: 23 August 2022. Payout ratio is a comfortable 36% and this is well supported by cash flows. Trailing yield: 2.2%. Lower than top quartile of German dividend payers (4.5%). Lower than average of industry peers (5.6%).
Reported Earnings • Aug 03First half 2022 earnings released: EPS: €1.29 (vs €1.66 in 1H 2021)First half 2022 results: EPS: €1.29 (down from €1.66 in 1H 2021). Revenue: €13.8b (up 9.2% from 1H 2021). Net income: €309.1m (down 23% from 1H 2021). Profit margin: 2.2% (down from 3.2% in 1H 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is expected to shrink by 22% compared to a 6.1% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.
お知らせ • Jul 30Umicore SA to Report Fiscal Year 2022 Results on Feb 16, 2023Umicore SA announced that they will report fiscal year 2022 results on Feb 16, 2023
Upcoming Dividend • Apr 27Upcoming dividend of €0.39 per shareEligible shareholders must have bought the stock before 02 May 2022. Payment date: 04 May 2022. Payout ratio is a comfortable 31% and this is well supported by cash flows. Trailing yield: 2.3%. Lower than top quartile of German dividend payers (4.0%). Lower than average of industry peers (5.0%).
Reported Earnings • Mar 28Full year 2021 earnings released: EPS: €2.57 (vs €0.54 in FY 2020)Full year 2021 results: EPS: €2.57 (up from €0.54 in FY 2020). Revenue: €24.1b (up 16% from FY 2020). Net income: €619.0m (up 374% from FY 2020). Profit margin: 2.6% (up from 0.6% in FY 2020). The increase in margin was driven by higher revenue. Over the next year, revenue is expected to shrink by 83% compared to a 6.9% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.
Reported Earnings • Feb 18Full year 2021 earnings: EPS in line with expectations, revenues disappointFull year 2021 results: EPS: €2.57 (up from €0.54 in FY 2020). Revenue: €24.2b (up 17% from FY 2020). Net income: €619.0m (up 374% from FY 2020). Profit margin: 2.6% (up from 0.6% in FY 2020). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 1.5%. Over the next year, revenue is expected to shrink by 83% compared to a 6.5% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
Valuation Update With 7 Day Price Move • Dec 14Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to €37.04, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 10x in the Chemicals industry in Germany. Total returns to shareholders of 6.3% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €39.58 per share.
Executive Departure • Oct 12CEO & Member of Management Board Marc Grynberg has left the companyDuring their tenure, earnings grew by 16% annually compared to the industry average, which went down by 3.0%. On the 1st of October, Marc Grynberg was replaced as CEO by Mathias Miedreich after 12.9 years in the role. We don't have any record of a personal shareholding under Marc's name. A total of 2 executives have left over the last 12 months. The current median tenure of the management team is 1.50 years, which is considered inexperienced in the Simply Wall St Risk Model. Under Marc's leadership, the company delivered a total shareholder return of 1,017%.
Upcoming Dividend • Aug 13Upcoming dividend of €0.17 per shareEligible shareholders must have bought the stock before 20 August 2021. Payment date: 24 August 2021. Trailing yield: 1.3%. Lower than top quartile of German dividend payers (3.1%). Lower than average of industry peers (3.5%).
Reported Earnings • Aug 02First half 2021 earnings released: EPS €1.66 (vs €0.38 in 1H 2020)The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: €12.7b (up 27% from 1H 2020). Net income: €400.1m (up 340% from 1H 2020). Profit margin: 3.2% (up from 0.9% in 1H 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has increased by 1% per year.
Upcoming Dividend • Apr 26Upcoming dividend of €0.35 per shareEligible shareholders must have bought the stock before 03 May 2021. Payment date: 05 May 2021. Trailing yield: 2.0%. Lower than top quartile of German dividend payers (3.2%). Lower than average of industry peers (3.5%).
Is New 90 Day High Low • Mar 02New 90-day high: €49.17The company is up 31% from its price of €37.50 on 02 December 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €41.30 per share.
Reported Earnings • Feb 13Full year 2020 earnings released: EPS €0.54 (vs €1.20 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: €20.7b (up 18% from FY 2019). Net income: €130.5m (down 55% from FY 2019). Profit margin: 0.6% (down from 1.6% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has remained flat, which means it is well ahead of earnings.
Is New 90 Day High Low • Jan 21New 90-day high: €46.81The company is up 36% from its price of €34.38 on 23 October 2020. The German market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 22% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €14.88 per share.
Is New 90 Day High Low • Dec 30New 90-day high: €39.29The company is up 10.0% from its price of €35.61 on 01 October 2020. The German market is up 9.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 18% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €9.26 per share.
Is New 90 Day High Low • Oct 20New 90-day low: €34.74The company is down 23% from its price of €45.34 on 22 July 2020. The German market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €8.10 per share.
Is New 90 Day High Low • Sep 25New 90-day low: €35.75The company is down 16% from its price of €42.32 on 26 June 2020. The German market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €8.41 per share.